Department of Pharmacy, Shriners Hospital for Children, Cincinnati, Ohio, USA.
Shriners Hospital for Children, Cincinnati, Ohio, USA.
J Burn Care Res. 2020 Jul 3;41(4):739-742. doi: 10.1093/jbcr/iraa048.
Topically applied antimicrobials are key to the prevention of infection and mortality in the acute burn population. The purpose of this study was to determine the in vitro effectiveness of commercially available topical antimicrobials, as well as topical preparations that were compounded in our burn care institution. One-hundred twenty microorganisms were tested against these topical antimicrobials and in vitro effectiveness was observed. Results showed that compounded preparations of 1:1:1 + Double Antibiotic (1 part bacitracin: 1 part silver sulfadiazine: 100,000 units/g nystatin + 5 mg/g neomycin sulfate + 500 units/g polymyxin B) and 3:1 + Double Antibiotic (3 part bacitracin: 1 part silver sulfadiazine + 5mg/g neomycin sulfate + 500 units/g polymyxin B) were effective against 100% of the isolates tested. Other topical agents showed moderate effectiveness, thus demonstrating the need for multiple topical agents to reach a broad spectrum of microorganisms. However, the development of topical antimicrobial resistance needs further study.
局部应用的抗菌药物是预防急性烧伤人群感染和死亡的关键。本研究旨在确定市售局部抗菌药物以及我们烧伤医疗机构配制的局部制剂的体外有效性。对 120 种微生物进行了这些局部抗菌药物的测试,并观察了体外效果。结果表明,1:1:1+双抗生素(1 份杆菌肽:1 份磺胺嘧啶银:100,000 单位/克制霉菌素+5mg/g 硫酸新霉素+500 单位/克多粘菌素 B)和 3:1+双抗生素(3 份杆菌肽:1 份磺胺嘧啶银+5mg/g 硫酸新霉素+500 单位/克多粘菌素 B)的复方制剂对测试的 100%分离株有效。其他局部药物显示出中等效力,因此需要多种局部药物来达到广谱微生物的效果。然而,局部抗菌药物耐药性的发展需要进一步研究。